News | February 20, 2009

AMI Says Prepare for Changes in PET Coverage Under NOPR


February 20, 2009 - The Academy of Molecular Imaging recommends that PET imaging facilities closely monitor NOPR communications and be prepared for coverage changes on the date the final coverage decision is issued.

On January 6, 2009, CMS proposed significant changes to current coverage regarding Medicare's coverage of PET imaging under NOPR (see http://). Under the proposal, Medicare will provide coverage on a routine basis for many of the indications now reimbursed under NOPR. However, other indications would be covered only under a successor Coverage with Evidence Development (CED) program which likely will be somewhat different than the current NOPR program.

Medicare will publish its final coverage statement on or before April 6, 2009. The new policy becomes effective on the day it is published. The NOPR believes it should be possible to have a successor CED program in place when the NCD is published. However, until the day the new NCD is published, we will not know the details of the final coverage policy, whether any new codes or modifiers must be used for claims, nor whether a successor NOPR program has been cleared by CMS.

Although the new coverage policy will be effective on the day it is published, Medicare Contractors are allowed at least 30 days to implement required changes in their claims processing software, and in
their local coverage policies.

Each site should closely monitor NOPR communications, and be prepared for coverage changes on the date the final coverage decision is issued. In the past, when major coverage or fee schedule changes occurred, some providers have held claims until their contractors have implemented the new edits. As soon as additional information becomes available, we will make it available to participating PET facilities via these e-mail announcements and the NOPR website.

For more information: www.ami-imaging.org and www3.cms.hhs.gov/mcd/viewdraftdecisionmemo.asp?id=218


Related Content

News | PET Imaging

June 18, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Home June 18, 2024
Home
News | PET Imaging

June 14, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Home June 14, 2024
Home
News | PET Imaging

October 5, 2023 — Jubilant DraxImage Inc., a wholly-owned subsidiary of Jubilant Pharma Limited, has entered into an ...

Home October 05, 2023
Home
News | PET Imaging

December 1, 2022 — A new method for determining whether patients with heart disease need coronary stents or bypass ...

Home December 01, 2022
Home
News | PET Imaging

September 14, 2022 — GE Healthcare and Lantheus Holdings Inc have announced that the recent Phase III clinical trial of ...

Home September 14, 2022
Home
News | PET Imaging

August 25, 2022 — The results of “A Phase 3, Open-label, Multicenter Study of Flurpiridaz (F18) Injection for Positron ...

Home August 25, 2022
Home
News | PET Imaging

June 15, 2022 — Poor functional outcomes after a heart attack can be predicted with a new PET imaging agent, 68Ga-FAPI ...

Home June 15, 2022
Home
Technology | PET Imaging

December 5, 2018 — Subtle Medical announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market ...

Home December 05, 2018
Home
News | PET Imaging

July 17, 2018 — A new way to examine stress and inflammation in the heart will help Parkinson’s researchers test new ...

Home July 17, 2018
Home
News | PET Imaging

July 7, 2017 — Blood clots in veins and arteries can lead to heart attack, stroke and pulmonary embolism, which are ...

Home July 07, 2017
Home
Subscribe Now